US 8017321
Gefitinib sensitivity-related gene expression and products and methods related thereto
granted A61PA61P35/00
Quick answer
US patent 8017321 (Gefitinib sensitivity-related gene expression and products and methods related thereto) held by The Regents of the University of Colorado, a Body Corporate expires Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Sep 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61P, A61P35/00